ArticleClinics (Sao Paulo, Brazil)2015

Treatment with dasatinib or nilotinib in chronic myeloid leukemia patients who failed to respond to two previously administered tyrosine kinase inhibitors--a single center experience.

Beatriz Felicio Ribeiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.